Insider Trading & Ownership of Marc Tessier-Lavigne

Location: South San Francisco, CA
Summary: The estimated net worth of Marc Tessier-Lavigne is at least $37,224,802 dollars as of 05 Jun 2025. Marc Tessier-Lavigne is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $34.91M. Marc Tessier-Lavigne is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $2.32M.
Signature: /s/ Tyler Nielsen, by power of attorney
All Insider Reports: All Insider Reports

Notify me when Marc Tessier-Lavigne files a new Insider Trading report.

Ownership of Marc Tessier-Lavigne

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
DNLI	Denali Therapeutics Inc.	Director	$34,909,435			03 Jun 2025
REGN	REGENERON PHARMACEUTICALS, INC.	Director	$2,315,367			03 Jan 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.